T. Foster Robert's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 32,900 Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 21, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharma Inc | T. Foster Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2023 | 32,900 | 32,900 | - | - | Stock Option (right to buy) | |
| Aurinia Pharma Inc | Robert T. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2023 | 20,383 | 20,383 | - | - | Restricted Stock Units | |
| Hepion Pharmaceuticals Inc | Robert T. Foster | Director, CEO, CSO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,900,000 | 2,501,879 | - | - | Stock Options |